Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Xia Yu (actor)

Tracked across 1 events · 6 articles · First seen Jul 20, 2026 · Last active Sep 13, 2026

Sentiment
5
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 5
Tech
Akeso announced that a pre-specified interim analysis of overall survival (OS) in the Phase III HARMONi-2 (AK112-303) trial, assessed by the Independent Data Monitoring Committee, met the key secondary OS endpoint. Ivonescimab, Akeso's first-in-class PD-1/VEGF…
Impact: Xia Yu (actor), Akeso's Founder, Chairwoman, President and CEO, publicly framed the OS results as reinforcing ivonescimab's clinical value and broader solid-tumor potential.
Jul 20, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Xia Yu (actor) live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.